RF Micro Devices Inc. (NASDAQ:RFMD) has been on the move lately as the stock has risen by 18.7% in the past four weeks, and it is currently trading well above its 20-Day SMA. While there can be no telling for sure, it is certainly encouraging that earnings estimates have risen in the past few weeks on…
Verizon Communications Inc. (NYSE:VZ) and thePlatform, the leading white-label video publishing company and an independent subsidiary of Comcast, today announced a new strategic alliance to accelerate major media and pay-TV operators’ plans for multiscreen video delivery. Verizon Communications Inc. (NYSE:VZ)’s stock on 30 July traded at beginning with a price of $51.94and when day-trade ended…
Citigroup Inc. reissued their sell rating on shares of AK Steel Holding (NYSE:AKS) in a research report released on Thursday morning. Citigroup Inc. currently has a $2.00 price objective on the stock, down from their previous price objective of $2.30. AK Steel Holding Corporation (NYSE:AKS) belongs to Basic Materials sector. Its net profit margin is…
Facebook Inc (NASDAQ:FB)’s New Year Resolution: More Video Ads in News Feed. The amount of video on Facebook Inc.’s news feed more than tripled last year, as many users and advertisers discovered the option for the first time. How much bigger video will get on the social network depends largely on Fidji Simo. Facebook Inc…
Jefferies Group reaffirmed their hold rating on shares of Blucora (NASDAQ:BCOR) in a report released on Thursday. Jefferies Group currently has a $15.00 price objective on the stock, down from their previous price objective of $17.00. Blucora, Inc. (NASDAQ:BCOR) belongs to Technology sector. Its net profit margin is 4.90% and weekly performance is -3.97%. On…
Actavis PLC (NYSE:ACT) agreed to pay about $66 billion for Allergan Inc., the maker of the antiwrinkle treatment Botox, in the year’s biggest pharmaceutical deal. The cash-and-stock purchase, in which Actavis will pay $219 a share, also puts an end to Valeant Pharmaceuticals International Inc.’s months-long hostile takeover fight for Allergan, a move backed by…
